|Bid||279.26 x 100|
|Ask||400.00 x 100|
|Day's Range||316.52 - 321.60|
|52 Week Range||244.28 - 330.00|
|PE Ratio (TTM)||20.93|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Analysts at Argus Research turned bullish on Bioverativ Inc (NASDAQ: BIVV ) as the company could establish itself as a profitable biotech within the hemophilia and blood disorders space. The firm's Jasper ...
Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. Clearly, this is a momentum stock, so it will never give us a clear signal for entry. More often than not, traders tend to overshoot with the price action of momentum stocks.
With the market grinding higher, some breakouts struggle. But Apple, Microsoft, Biogen, Alexion Pharmaceuticals, Wynn Resorts and Electronic Arts are holding in buy zones after breaking out several days or weeks ago.